Literature DB >> 6890045

Asymmetric septal hypertrophy and borderline hypertension.

M Safar, J R Benessiano, A L Hornysk.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6890045     DOI： 10.1016/0167-5273(82)90015-8

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  4 in total

Review 1.  Therapeutic effect on left ventricular hypertrophy by different antihypertensive drugs.

Authors:  W Motz; B E Strauer
Journal:  Clin Investig       Date:  1992

2.  Increased gene expression of plasminogen activators and inhibitors in left ventricular hypertrophy.

Authors:  C M Bloor; L Nimmo; M D McKirnan; Y Zhang; F C White
Journal:  Mol Cell Biochem       Date:  1997-11       Impact factor: 3.396

Review 3.  Basal Septal Hypertrophy as the Early Imaging Biomarker for Adaptive Phase of Remodeling Prior to Heart Failure.

Authors:  Fatih Yalçin; Hulya Yalçin; Nagehan Küçükler; Serbay Arslan; Oguz Akkuş; Alparslan Kurtul; Maria Roselle Abraham
Journal:  J Clin Med       Date:  2021-12-24       Impact factor: 4.241

Review 4.  Hemodynamic stress and microscopic remodeling.

Authors:  Fatih Yalçin; Hulya Yalçin; Roselle Abraham; Theodore P Abraham
Journal:  Int J Cardiol Cardiovasc Risk Prev       Date:  2021-11-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.